Published in J Virol on December 01, 2003
Exacerbation of established pulmonary fibrosis in a murine model by gammaherpesvirus. Am J Respir Crit Care Med (2008) 1.53
Inhibition of NF-kappaB activation in vivo impairs establishment of gammaherpesvirus latency. PLoS Pathog (2007) 1.39
Hepatitis C virus stimulates the expression of cyclooxygenase-2 via oxidative stress: role of prostaglandin E2 in RNA replication. J Virol (2005) 1.22
Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression. J Virol (2006) 1.18
Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus. J Virol (2006) 1.13
Inhibition of cyclooxygenase activity reduces rotavirus infection at a postbinding step. J Virol (2004) 0.92
Systematic mutagenesis of the murine gammaherpesvirus 68 M2 protein identifies domains important for chronic infection. J Virol (2008) 0.89
Potential secondary pathogenic role for bovine herpesvirus 4. J Clin Microbiol (2005) 0.89
Cyclooxygenase-1 and -2 are required for production of infectious pseudorabies virus. J Virol (2004) 0.86
The inflammatory kinase MAP4K4 promotes reactivation of Kaposi's sarcoma herpesvirus and enhances the invasiveness of infected endothelial cells. PLoS Pathog (2013) 0.84
Differential COX-2 induction by viral and bacterial PAMPs: Consequences for cytokine and interferon responses and implications for anti-viral COX-2 directed therapies. Biochem Biophys Res Commun (2013) 0.83
Cyclooxygenase activity is important for efficient replication of mouse hepatitis virus at an early stage of infection. Virol J (2007) 0.82
Proteins of the secretory pathway govern virus productivity during lytic gammaherpesvirus infection. J Cell Mol Med (2008) 0.82
TLR9-induced interferon β is associated with protection from gammaherpesvirus-induced exacerbation of lung fibrosis. Fibrogenesis Tissue Repair (2011) 0.81
Prostaglandin E2 reduces the release and infectivity of new cell-free virions and cell-to-cell HIV-1 transfer. PLoS One (2014) 0.81
Systemic therapy for cervical cancer with potentially regulatable oncolytic adenoviruses. PLoS One (2008) 0.80
Inflammatory and oxidative stress in rotavirus infection. World J Virol (2016) 0.76
Role of Modulator of Inflammation Cyclooxygenase-2 in Gammaherpesvirus Mediated Tumorigenesis. Front Microbiol (2017) 0.75
Prostaglandins and leukotrienes: advances in eicosanoid biology. Science (2001) 11.23
Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem (2000) 8.86
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology (1994) 8.79
Prostanoid receptors: structures, properties, and functions. Physiol Rev (1999) 8.60
Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol (1997) 7.71
TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem (1991) 5.62
Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J Gen Virol (1992) 5.42
Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci U S A (1991) 5.07
Virological and pathological features of mice infected with murine gamma-herpesvirus 68. J Gen Virol (1992) 5.02
Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. Proc Natl Acad Sci U S A (1998) 4.33
Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages. J Exp Med (1978) 3.38
Prostaglandin synthase 2. Biochim Biophys Acta (1996) 3.14
Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature (1998) 2.88
Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J Exp Med (1996) 2.71
NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins (1994) 2.60
Natural history of murine gamma-herpesvirus infection. Philos Trans R Soc Lond B Biol Sci (2001) 2.50
Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68. Am J Pathol (1994) 2.49
Rta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency. J Virol (2000) 2.35
Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J Exp Med (1996) 2.28
Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res (1998) 2.11
Transcription program of murine gammaherpesvirus 68. J Virol (2003) 1.96
Characterization of gammaherpesvirus 68 gene 50 transcription. J Virol (2000) 1.84
Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc Natl Acad Sci U S A (2002) 1.77
Transcriptome profile of murine gammaherpesvirus-68 lytic infection. J Gen Virol (2003) 1.75
Synergistic stimulation of fibroblast prostaglandin production by recombinant interleukin 1 and tumor necrosis factor. J Immunol (1987) 1.73
Selective inhibition of COX-2 improves early survival in murine endotoxemia but not in bacterial peritonitis. Am J Physiol Lung Cell Mol Physiol (2001) 1.71
Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E2. J Biol Chem (1999) 1.65
Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc Natl Acad Sci U S A (2001) 1.63
Function of Rta is essential for lytic replication of murine gammaherpesvirus 68. J Virol (2001) 1.61
Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages. J Biol Chem (2000) 1.57
The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. J Clin Invest (2002) 1.55
Anti-inflammatory drugs and their mechanism of action. Inflamm Res (1998) 1.48
Ligand-induced prostaglandin synthesis requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages. J Biol Chem (1994) 1.40
Gammaherpesvirus lytic gene expression as characterized by DNA array. J Virol (2002) 1.33
Concordant induction of prostaglandin E2 synthase with cyclooxygenase-2 leads to preferred production of prostaglandin E2 over thromboxane and prostaglandin D2 in lipopolysaccharide-stimulated rat peritoneal macrophages. Biochem Biophys Res Commun (1997) 1.30
Increased cyclooxygenase-2 (cox-2) expression and activity in a murine model of metastatic breast cancer. Int J Cancer (2001) 1.24
Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells. Circ Res (1998) 1.21
Quantitative analysis of the acute and long-term CD4(+) T-cell response to a persistent gammaherpesvirus. J Virol (1999) 1.15
In vitro and in vivo inhibition of murine gamma herpesvirus 68 replication by selected antiviral agents. Antimicrob Agents Chemother (1998) 1.14
Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors. Inflamm Res (2000) 1.14
Characterization of a monoclonal antibody that neutralizes the activity of prostaglandin E2. J Immunol (1995) 1.10
Poxvirus-induced alteration of arachidonate metabolism. Proc Natl Acad Sci U S A (1993) 1.07
A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2. Clin Cancer Res (2001) 1.04
Murine gammaherpesvirus-68 infection of and persistence in the central nervous system. J Gen Virol (2000) 1.02
Antiviral activity of cyclopentenone prostanoids. Trends Microbiol (1997) 1.02
Prostaglandin G/H synthase isoenzyme 2 expression in fibroblasts: regulation by dexamethasone, mitogens, and oncogenes. Arch Biochem Biophys (1993) 1.01
Expression of cyclooxygenase-2 in chronic hepatitis B and the effects of anti-viral therapy. Aliment Pharmacol Ther (2002) 0.99
Synergistic activation of the human cytomegalovirus major immediate early promoter by prostaglandin E2 and cytokines. Exp Lung Res (1998) 0.98
Reciprocal interactions between human T-lymphotropic virus type 1 and prostaglandins: implications for viral transmission. J Virol (2001) 0.97
Regulation of cyclooxygenase-2 expression by macrophages in response to double-stranded RNA and viral infection. J Immunol (2003) 0.96
Suppression of Japanese encephalitis virus infection by non-steroidal anti-inflammatory drugs. J Gen Virol (2002) 0.96
COX-2 and colon cancer. Inflamm Res (1998) 0.96
Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus. J Virol (2000) 0.95
2'-Deoxy-5-ethyl-beta-4'-thiouridine inhibits replication of murine gammaherpesvirus and delays the onset of virus latency. Antivir Chem Chemother (1999) 0.92
EBV suppresses prostaglandin E2 biosynthesis in human monocytes. J Immunol (2000) 0.92
Activation of monocyte cyclooxygenase-2 gene expression by human herpesvirus 6. Role for cyclic AMP-responsive element-binding protein and activator protein-1. J Biol Chem (2002) 0.92
The prophylactic use of cyclooxygenase inhibitors in recurrent herpes simplex infections. Br J Dermatol (1990) 0.89
Prostaglandin E2 Up-regulates HIV-1 long terminal repeat-driven gene activity in T cells via NF-kappaB-dependent and -independent signaling pathways. J Biol Chem (1998) 0.87
Cyclooxygenase selectivity and the risk of gastro-intestinal complications of various non-steroidal anti-inflammatory drugs: a clinical consideration. Inflamm Res (1998) 0.85
Enhanced expression of haem oxygenase-1 by nitric oxide and antiinflammatory drugs in NIH 3T3 fibroblasts. Br J Pharmacol (2000) 0.85
Virus self-improvement through inflammation: no pain, no gain. Proc Natl Acad Sci U S A (2002) 0.85
Constitutive expression of the cyclooxygenase-2 gene in T-cell lines infected with human T cell leukemia virus type I. Int J Cancer (2001) 0.85
NSAID treatment suppresses VSV propagation in mouse CNS. Virology (2000) 0.85
The regulation and role of TIS10 prostaglandin synthase-2. Adv Prostaglandin Thromboxane Leukot Res (1995) 0.84
Selective inhibition of COX-2 is beneficial to mice infected intranasally with VSV. Prostaglandins Other Lipid Mediat (2002) 0.83
From indomethacin to a selective COX-2 inhibitor. Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors. Adv Exp Med Biol (1997) 0.83
Effect of indomethacin on ultraviolet radiation-induced recurrent herpes simplex virus disease in guinea-pigs. J Gen Virol (1993) 0.83
Prostaglandin E in the treatment of recurrent hepatitis B infection after orthotopic liver transplantation. Transplantation (1994) 0.82
The effect of indomethacin, prostaglandin E2 and interferon on the multiplication of herpes simplex virus type 1 in human lymphoid cells. Antiviral Res (1990) 0.81
Caspase-1 inhibitors abolish deleterious enhancement of COX-2 expression induced by HIV-1 gp120 in human neuroblastoma cells. Toxicol Lett (2003) 0.81
Oral prostaglandin (PGE2) therapy for chronic viral hepatitis B and C. J Viral Hepat (1999) 0.79
Inhibition of multiplication of parainfluenza 3 virus in prostaglandin-treated WISH cells. Arch Virol (1975) 0.79
Relationship between the prostaglandin cascade and virus infection. Acta Virol (1990) 0.77
Selective inhibitors of COX-2. Agents Actions Suppl (1995) 0.76
IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity (2002) 6.85
Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation. Cell Stem Cell (2008) 5.40
Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med (2006) 4.41
Low early-life social class leaves a biological residue manifested by decreased glucocorticoid and increased proinflammatory signaling. Proc Natl Acad Sci U S A (2009) 4.11
Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitors. Clin Cancer Res (2006) 2.49
Closed-loop control of cellular functions using combinatory drugs guided by a stochastic search algorithm. Proc Natl Acad Sci U S A (2008) 2.22
NF-kappaB inhibits gammaherpesvirus lytic replication. J Virol (2003) 2.15
Fluorescent imaging of single nanoparticles and viruses on a smart phone. ACS Nano (2013) 2.14
Sleep loss activates cellular inflammatory signaling. Biol Psychiatry (2008) 2.11
Identification of viral genes essential for replication of murine gamma-herpesvirus 68 using signature-tagged mutagenesis. Proc Natl Acad Sci U S A (2005) 1.98
Transcription program of murine gammaherpesvirus 68. J Virol (2003) 1.96
Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin Cancer Res (2009) 1.93
Characterization of interactions between RTA and the promoter of polyadenylated nuclear RNA in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J Virol (2002) 1.83
Identification of proteins associated with murine gammaherpesvirus 68 virions. J Virol (2003) 1.75
Gamma-herpesvirus kinase actively initiates a DNA damage response by inducing phosphorylation of H2AX to foster viral replication. Cell Host Microbe (2007) 1.71
Three-dimensional visualization of gammaherpesvirus life cycle in host cells by electron tomography. Structure (2010) 1.65
Transcriptional regulation of the interleukin-6 gene of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus). J Virol (2002) 1.60
Quantitative imaging of single, unstained viruses with coherent x rays. Phys Rev Lett (2008) 1.52
Systematic comparison of the human saliva and plasma proteomes. Proteomics Clin Appl (2009) 1.51
Murine gammaherpesvirus 68 open reading frame 31 is required for viral replication. J Virol (2004) 1.40
Quantitative assessment of the association between CYP1A1 A4889G polymorphism and endometrial cancer risk. Tumour Biol (2013) 1.39
Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients. Hum Gene Ther (2004) 1.37
Transcriptional control of monocyte gene expression in post-traumatic stress disorder. Dis Markers (2011) 1.36
Comparative study of regulation of RTA-responsive genes in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J Virol (2003) 1.36
Persistent gammaherpesvirus replication and dynamic interaction with the host in vivo. J Virol (2008) 1.36
MicroRNAs encoded by Kaposi's sarcoma-associated herpesvirus regulate viral life cycle. EMBO Rep (2010) 1.34
Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus. PLoS Pathog (2007) 1.32
Viral Bcl-2-mediated evasion of autophagy aids chronic infection of gammaherpesvirus 68. PLoS Pathog (2009) 1.31
Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-kappaB and JNK/AP1 pathways. Oncogene (2003) 1.31
Conserved herpesviral kinase promotes viral persistence by inhibiting the IRF-3-mediated type I interferon response. Cell Host Microbe (2009) 1.30
High-resolution functional profiling of hepatitis C virus genome. PLoS Pathog (2008) 1.30
Thymidine kinase 2 mutations in autosomal recessive progressive external ophthalmoplegia with multiple mitochondrial DNA deletions. Hum Mol Genet (2011) 1.26
ORF18 is a transfactor that is essential for late gene transcription of a gammaherpesvirus. J Virol (2006) 1.24
The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production. Hepatology (2009) 1.21
Adrenergic inhibition of innate anti-viral response: PKA blockade of Type I interferon gene transcription mediates catecholamine support for HIV-1 replication. Brain Behav Immun (2006) 1.21
Rta of the human herpesvirus 8/Kaposi sarcoma-associated herpesvirus up-regulates human interleukin-6 gene expression. Blood (2002) 1.20
B cell terminal differentiation factor XBP-1 induces reactivation of Kaposi's sarcoma-associated herpesvirus. FEBS Lett (2007) 1.16
ORF30 and ORF34 are essential for expression of late genes in murine gammaherpesvirus 68. J Virol (2008) 1.14
Label-free, electrical detection of the SARS virus N-protein with nanowire biosensors utilizing antibody mimics as capture probes. ACS Nano (2009) 1.14
Murine gamma-herpesvirus 68 hijacks MAVS and IKKbeta to initiate lytic replication. PLoS Pathog (2010) 1.14
Identification of cis sequences required for lytic DNA replication and packaging of murine gammaherpesvirus 68. J Virol (2004) 1.13
MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart. Circ Res (2010) 1.12
Murine gammaherpesvirus 68 open reading frame 24 is required for late gene expression after DNA replication. J Virol (2007) 1.11
Experimental bioluminescence tomography with fully parallel radiative-transfer-based reconstruction framework. Opt Express (2009) 1.10
Structure-guided engineering of human thymidine kinase 2 as a positron emission tomography reporter gene for enhanced phosphorylation of non-natural thymidine analog reporter probe. J Biol Chem (2011) 1.10
Microfluidic device architecture for electrochemical patterning and detection of multiple DNA sequences. Langmuir (2008) 1.09
Early establishment of gamma-herpesvirus latency: implications for immune control. J Immunol (2005) 1.09
Genetic analysis of H1N1 influenza virus from throat swab samples in a microfluidic system for point-of-care diagnostics. J Am Chem Soc (2011) 1.09
Inhibition of gammaherpesvirus replication by RNA interference. J Virol (2003) 1.08
beta-Adrenoreceptors reactivate Kaposi's sarcoma-associated herpesvirus lytic replication via PKA-dependent control of viral RTA. J Virol (2005) 1.08
Two kinetic patterns of epitope-specific CD8 T-cell responses following murine gammaherpesvirus 68 infection. J Virol (2010) 1.08
Systematic identification of H274Y compensatory mutations in influenza A virus neuraminidase by high-throughput screening. J Virol (2012) 1.07
mRNA display selection of a high-affinity, modification-specific phospho-IkappaBalpha-binding fibronectin. ACS Chem Biol (2008) 1.07
B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (2010) 1.06
Oxidative stress induces reactivation of Kaposi's sarcoma-associated herpesvirus and death of primary effusion lymphoma cells. J Virol (2010) 1.05
TANK-binding kinase-1 plays an important role during in vitro and in vivo type I IFN responses to DNA virus infections. J Immunol (2009) 1.04
Murine gammaherpesvirus 68 open reading frame 45 plays an essential role during the immediate-early phase of viral replication. J Virol (2005) 1.04
Spectrally resolved bioluminescence tomography with the third-order simplified spherical harmonics approximation. Phys Med Biol (2009) 1.02
A repetitive region of gammaherpesvirus genomic DNA is a ligand for induction of type I interferon. J Virol (2007) 1.02
Prostratin and bortezomib are novel inducers of latent Kaposi's sarcoma-associated herpesvirus. Antivir Ther (2005) 1.02
Human immunodeficiency virus type-1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus through induction of KSHV Rta. Virology (2002) 1.01
Overexpression of COX-2 in human osteosarcoma cells decreases proliferation and increases apoptosis. Cancer Res (2006) 1.00
Murine gammaherpesvirus 68 ORF52 encodes a tegument protein required for virion morphogenesis in the cytoplasm. J Virol (2007) 1.00
Preserved heart function and maintained response to cardiac stresses in a genetic model of cardiomyocyte-targeted deficiency of cyclooxygenase-2. J Mol Cell Cardiol (2010) 0.99
A novel inhibitory mechanism of mitochondrion-dependent apoptosis by a herpesviral protein. PLoS Pathog (2007) 0.99
Systematic quantitative characterization of cellular responses induced by multiple signals. BMC Syst Biol (2011) 0.99
On-chip cytometry using plasmonic nanoparticle enhanced lensfree holography. Sci Rep (2013) 0.99
Single-round, multiplexed antibody mimetic design through mRNA display. Angew Chem Int Ed Engl (2012) 0.98
Integrative systems control approach for reactivating Kaposi's sarcoma-associated herpesvirus (KSHV) with combinatory drugs. Integr Biol (Camb) (2009) 0.98
Generation of a latency-deficient gammaherpesvirus that is protective against secondary infection. J Virol (2004) 0.98
Internet access for delivery of health information to South Australians older than 50. Aust N Z J Public Health (2008) 0.97
Fate modeling of phenanthrene with regional variation in Tianjin, China. Environ Sci Technol (2003) 0.97
A replication-deficient murine gamma-herpesvirus blocked in late viral gene expression can establish latency and elicit protective cellular immunity. J Immunol (2007) 0.97